You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
【瑞通認股證牛熊證】石藥未止跌見一個月低位 銀娛向上挑戰250天線 石藥購25482 沽28344/ 銀河牛61488 熊60495/ 美團最貼牛61724 熊57595
阿思達克 12-02 10:13

市場憂慮中美關係再次緊張,道指上周五收報28051點,跌112點(或0.4%),全月計則累升3.7%。中國11月官方製造業PMI升上50.2,勝市場預期。

恆指上周五收報26346點,挫547點(或2%),整個11月亦累跌2%。今早一度回升過百點,高位觸及26500點水平,其後升幅曾收窄。恆指好倉(牛證及認購權證)上周五淨流入逾1.6億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出逾1.7億元,反映投資者預期港股將見技術性反彈。上周五恆指牛證街貨重貨區為收回價26200至26299點,而熊證街貨重貨區為收回價27400至27499點。

石藥(01093)上周五最多瀉超過12%,收市跌9.7%,報17.82元,是當日表現最差藍籌。股份在成交急增下失50天線,14日RSI跌至35的接近超賣水平,並在當日錄逾2.6億元北水淨沽出。內地公布新版醫保藥品名單,多種藥品價格下降六成以上,另有券商料石藥旗下一款熱銷藥品或被納入名單,有降價壓力。石藥今早跌勢未止,跌超過2%,失守17.5元水平,見一個月低位。輪證資金流方面,上周五分別有逾580萬元和136萬元淨流出其好倉和淡倉。

近期多間券商包括中信証券(06030)宣布清理重複帳戶,實施一人一戶。中信証券上周五報14.54元,跌幅2.5%,失100天線。今早升約2%,高見14.9元水平後,升幅收窄。上周五分別有35萬元和1萬元淨流出其好倉和淡倉。

澳門上月博彩毛收入228.77億澳門元,按年跌8.5%,不過略好過市場預期。銀娛(00027)上周五跌逾2.5%,盤中曾跌穿51元,失50天線。今早升逾1%,向上挑戰52元水平,此亦是目前250天線所處的位置。上周五有120萬元淨流入其好倉,淡倉同日則有逾160萬元淨流出。

全國攜號轉網正式全國上線,投資者憂慮客戶流走及引發減價戰。有券商指中移動(00941)在上季錄得客戶攜號轉台流出。中移動股價連日受壓,上周五收跌2.1%報59元,盤中曾見58.85元創10年低,4個交易日累跌4.8%。今早高開逾1%,於60元關口遇阻,其後徘徊在59元水平。上周五有逾240萬元淨流入其好倉,淡倉同日則有26萬元淨流出。

瑞通相關認股證之選擇:

石藥輕微價外、中短期購25482,行使價:19.8元,2020年3月到期,實際槓桿:6.6倍

石藥價外、中年期沽28344,行使價:14.68元,2020年7月到期,實際槓桿:3.3倍

中証貼價、中短期購27550,行使價:15.19元,2020年3月到期,實際槓桿:7.5倍

銀河輕微價外、中短期購24070,行使價:58.8元,2020年4月到期,實際槓桿:8倍

銀河輕微價外、中短期沽11016,行使價:46.8元,2020年4月到期,實際槓桿:5.9倍

中移輕微價外、中年期購13317,行使價:63.88元,2020年6月到期,實際槓桿:10.2倍

中移價內、中短期沽22475,行使價:60.88元,2020年3月到期,實際槓桿:9.2倍

阿里輕微價內、長期購13511,行使價:197.8元,2020年11月到期,實際槓桿:3.7倍

阿里貼價、中短期購13507,行使價:208元,2020年5月到期,實際槓桿:5.5倍

瑞通相關牛熊證之選擇:

恆指N類牛證58812,收回價及行使價:25820點,槓桿比率:34倍

恆指N類熊證61726,收回價及行使價:26880點,槓桿比率:44.9倍

中証牛證61617,收回價:13.1元,槓桿比率:5.4倍

銀河牛證61488,收回價:48.6元,槓桿比率:9.8倍

銀河熊證60495,收回價:55.5元,槓桿比率:9.8倍

美團牛證61724,收回價:99.44元,槓桿比率:10.3倍

美團熊證57595,收回價:109.9元,槓桿比率:11.5倍重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account